Skip to main content
Equibles

AdvisorShares Investments LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1425930 BETHESDA, MD
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$100,887
-$57,065 QoQ
Shares Held
438,643
+58.3% QoQ
Ownership
0.988%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 48 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AdvisorShares Investments LLC holds $30,987,010 across 21 Biotechnology names. VTGN ranks #19 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 121,381 $5,709,762
2 ATAI
AtaiBeckley Inc.
 882,892 $4,652,840
3 RLMD
Relmada Therapeutics, Inc.
 438,901 $3,037,194
4 NRXP
NRX Pharmaceuticals, Inc.
 659,018 $2,695,383
5 HELP
Cybin Inc.
 292,711 $1,934,819
6 GHRS
GH Research PLC
 71,267 $1,915,656
7 ANRO
Alto Neuroscience, Inc.
 70,748 $1,867,039
8 DRUG
Bright Minds Biosciences Inc.
 24,274 $1,704,034

All Filings in VTGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $100,887 438,643
2026-03-31 $157,952 277,110
2025-12-31 $165,124 250,188
2025-09-30 $734,842 206,998
2025-06-30 $406,228 203,114
2025-03-31 $397,785 159,114
2024-12-31 $294,439 99,810
2024-09-30 $204,017 67,780
2024-06-30 $180,194 51,780
2024-03-31 $380,534 72,071
2023-12-31 $279,158 54,311